GlassScriptPhysician profile
Shorena Thomas
NPI 1962927285
$18,637.57
in general payments reported to CMS, 2019-2025
55 companies · $5,132 in 2025
The $5,132 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,943 · 2022: $2,633 · 2023: $3,298 · 2024: $5,632 · 2025: $5,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,947.27 |
| Education | $114.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $3,133.87 | 2021-2025 | Zilbrysq, Briviact, Fintepla |
| Biogen, INC. | $1,808.61 | 2021-2025 | Vumerity, Tysabri, Leqembi |
| Neurocrine Biosciences, INC. | $1,299.04 | 2021-2025 | Ingrezza |
| Alnylam Pharmaceuticals INC. | $996.20 | 2022-2025 | Amvuttra |
| Abbvie INC. | $796.40 | 2021-2025 | |
| Sk Life Science, INC. | $714.42 | 2023-2025 | Xcopri |
| Amneal Pharmaceuticals LLC | $649.51 | 2023-2025 | Crexont, Rytary, Ongentys |
| Eisai INC. | $622.04 | 2021-2025 | |
| Lilly USA, LLC | $587.74 | 2021-2025 | Kisunla, Amyvid, Reyvow |
| Teva Pharmaceuticals USA, INC. | $546.60 | 2021-2025 | Austedo, Austedo Xr, Austedo Xr |
| Neurelis, INC. | $537.67 | 2021-2025 | Valtoco |
| Alexion Pharmaceuticals, INC. | $534.15 | 2023-2025 | Ultomiris |
| Acadia Pharmaceuticals INC | $513.13 | 2021-2025 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $496.60 | 2021-2025 | |
| Argenx US, INC. | $491.15 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $385.21 | 2021-2025 | Rexulti, Vyepti |
| Grifols USA, LLC | $360.03 | 2022-2025 | Gamunex-C |
| Tg Therapeutics, INC. | $345.86 | 2024-2025 | |
| Mdd US Operations, LLC | $341.51 | 2023-2025 | Gocovri, Qelbree, Gocovri |
| Janssen Pharmaceuticals, INC | $332.68 | 2021-2022 | |
| Kyowa Kirin, INC. | $326.62 | 2023-2025 | Nourianz |
| Csl Behring | $301.04 | 2021-2022 | |
| Genentech USA, INC. | $265.50 | 2021-2025 | Ocrevus, Ocrevus Zunovo |
| Sunovion Pharmaceuticals INC. | $230.31 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $202.73 | 2021-2024 | Hyqvia, Gammagard |
| Vanda Pharmaceuticals INC. | $196.99 | 2021-2025 | Ponvory, Fanapt, Hetlioz |
| Pfizer INC. | $187.57 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $173.03 | 2022 | |
| Axsome Therapeutics, INC. | $127.61 | 2025 | Symbravo |
| Boston Scientific Corporation | $117.33 | 2023 | |
| Jazz Pharmaceuticals INC. | $117.10 | 2025 | |
| Merz Pharmaceuticals, LLC | $116.19 | 2024-2025 | Inbrija, Xeomin |
| Abbott Laboratories | $84.90 | 2023-2024 | Infinity |
| Amgen INC. | $78.96 | 2021-2025 | Uplizna |
| Tanabe Pharma America, INC. | $75.09 | 2024 | |
| Janssen Biotech, INC. | $63.16 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $57.01 | 2022-2023 | Firdapse |
| Banner Life Sciences, LLC | $47.87 | 2022 | |
| Supernus Pharmaceuticals, INC. | $38.83 | 2022-2023 | |
| Curonix LLC | $35.22 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceuticals, INC. | $29.98 | 2021 | |
| Medtronic, INC. | $29.72 | 2021 | |
| Azurity Pharmaceuticals, INC. | $28.88 | 2023 | Horizant |
| Avanir Pharmaceuticals, INC. | $23.53 | 2021 | |
| Avion Pharmaceuticals | $22.23 | 2023 | Dhivy |
| Allergan, INC. | $21.84 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.07 | 2022 | |
| Akcea Therapeutics, INC. | $17.93 | 2021 | |
| Genzyme Corporation | $17.04 | 2022 | |
| Impel Pharmaceuticals INC. | $16.76 | 2022 | |
| Acorda Therapeutics, INC | $16.12 | 2022 | |
| Aucta Pharmaceuticals, INC. | $15.21 | 2025 | Motpoly Xr |
| Scilex Pharmaceuticals INC. | $14.36 | 2024 | |
| Sumitomo Pharma America, INC. | $13.71 | 2024 | Aptiom |
| Arbor Pharmaceuticals, INC. | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shorena Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.